Haematologica, Vol 92, Issue 2, 267-268 doi:10.3324/haematol.10682
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naresh, K. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naresh, K. N.

Malignant Lymphomas

MUM1 expression dichotomizes follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes

Kikkeri N. Naresh

Department of Histopathology, Hammersmith Hospital & Imperial College, London, UK

Correspondence: Kikkeri N Naresh, Haematopathologist, Department of Histopathology, Hammersmith Hospital & Imperial College, Du Cane Road, W12 0HS, London UK. Phone: international +44.20.83833969. Fax: international +44.20.83838140. E-mail: k.naresh{at}imperial.ac.uk

We investigated the expression of MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4) in 46 cases of follicular lymphoma (FL) and correlated this with grade and expression of CD10, Bcl-6 and Ki-67. The analysis suggests that MUM1 expression dichotomizes FL into low-grade FL of CD10+/Bcl-6+/MUM1–/Ki-67low pheno-type, and high-grade FL of CD10+/–/Bcl-6+/weak/MUM1+/Ki-67high phenotype.

Key words: follicular lymphoma, MUM1, IRF4, Bcl-6, Bcl-2, CD10, Ki-67, germinal center, B-cell.




This article has been cited by other articles:


Home page
 Ann OncolHome page
J. W. Sweetenham, B. Goldman, M. L. LeBlanc, J. R. Cook, R. R. Tubbs, O. W. Press, D. G. Maloney, R. I. Fisher, L. M. Rimsza, R. M. Braziel, et al.
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study
Ann. Onc., October 29, 2009; (2009) mdp460v1.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Leich, I. Salaverria, S. Bea, A. Zettl, G. Wright, V. Moreno, R. D. Gascoyne, W.-C. Chan, R. M. Braziel, L. M. Rimsza, et al.
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations
Blood, July 23, 2009; 114(4): 826 - 834.
[Abstract] [Full Text] [PDF]